0000899866-20-000063.txt : 20200609
0000899866-20-000063.hdr.sgml : 20200609
20200609165959
ACCESSION NUMBER: 0000899866-20-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200609
DATE AS OF CHANGE: 20200609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ORLOFF JOHN J
CENTRAL INDEX KEY: 0001643941
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 20952601
MAIL ADDRESS:
STREET 1: C/O BAXALTA INCORPORATED
STREET 2: 1200 LAKESIDE DRIVE
CITY: BANNOCKBURN
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 4752302596
MAIL ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960111
4
1
wf-form4_159173638161609.xml
FORM 4
X0306
4
2020-06-08
0
0000899866
ALEXION PHARMACEUTICALS, INC.
ALXN
0001643941
ORLOFF JOHN J
C/O ALEXION PHARMACEUTICALS, INC
121 SEAPORT BOULEVARD
BOSTON
MA
02210
0
1
0
0
EVP, Research & Development
Common Stock, par value $.0001 per share
2020-06-08
4
F
0
2784
114.61
D
44529
D
This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
/s/ Douglas Barry, Attorney-in-Fact for John Orloff
2020-06-09